A strong EU IP framework guarantees future innovation for patients
19 May 2017 | By European Federation of Pharmaceutical Industries and Associations (EFPIA)
Intellectual Property (IP) could be considered the foundation for pharmaceutical innovation. In healthcare, innovation means improved health outcomes: avoiding illness; slowing disease progression; improving patients’ lives; and reducing overall costs for healthcare systems. With over 80 medicines approved every year – including some 30 new, approved substances – and over…